Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.
about
Fe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.Common hematological disorders in children.Circulating microRNAs as biomarkers for detection of autologous blood transfusionCardiac and Hepatic T2*-Weighted Magnetic Resonance Imaging in Transfusion Dependent Hemoglobinopathy in North West of Iran.Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.Current approach to iron chelation in children.Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload.Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload.Ability to determine the desferrioxamine-chelatable iron fractions of nontransferrin-bound iron using HPLC.A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy.A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.In vivo behavior of NTBI revealed by automated quantification system.
P2860
Q30416140-262EEAE9-CEC6-4995-9421-FF57446EAEE9Q33409673-DF424FE9-49AE-47D6-8A28-717A28210D5AQ34805271-7934A617-5214-404E-AC5C-18FC34AE3165Q36654077-5FEBB5E0-13C6-4A1B-9D79-0F50E50D501DQ37695691-EBB8A57B-CFAB-44DA-9B06-DD78E9987B82Q38197269-E02C3B8B-48C9-42CD-8CB2-35611F348FC3Q38608472-2EDCA172-9DB4-4ECC-BE55-0B548F12137AQ40896307-A3E874D5-3DCE-4732-89A4-E59851745289Q44060767-D3B310CB-B6B9-4D93-94DD-4C1657D59A37Q44286743-721837A2-6458-4E5E-820F-F8333C652FE0Q47931907-EA522B15-D507-4DC3-8775-6561987ED6FFQ53137184-3A4D0089-A433-4DDD-846B-095C76594C8E
P2860
Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Management of transfusional ir ...... cacy of iron chelating agents.
@ast
Management of transfusional ir ...... cacy of iron chelating agents.
@en
type
label
Management of transfusional ir ...... cacy of iron chelating agents.
@ast
Management of transfusional ir ...... cacy of iron chelating agents.
@en
prefLabel
Management of transfusional ir ...... cacy of iron chelating agents.
@ast
Management of transfusional ir ...... cacy of iron chelating agents.
@en
P2860
P356
P1476
Management of transfusional ir ...... cacy of iron chelating agents.
@en
P2093
Janet L Kwiatkowski
P2860
P304
P356
10.2147/JBM.S13065
P577
2011-09-21T00:00:00Z